financetom
Business
financetom
/
Business
/
Rumble Shares Jump After Offer to Buy, Operate TikTok in US
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Rumble Shares Jump After Offer to Buy, Operate TikTok in US
Mar 12, 2024 9:36 AM

12:20 PM EDT, 03/12/2024 (MT Newswires) -- Rumble (RUM) shares jumped 12% after the company offered to buy and operate TikTok in the US if ByteDance divests ownership in the social media platform.

"Rumble is ready to join a consortium with other parties seeking to acquire and operate TikTok inside the US," Chief Executive Officer Chris Pavlovski said Tuesday in a letter to ByteDance, according to a company post on X.

ByteDance did not immediately respond to a request for comment by MT Newswires.

The US House of Representatives is expected to pass legislation this week that would ban TikTok in the US unless ByteDance agrees to sell, media reports said Monday.

Price: 7.47, Change: +0.80, Percent Change: +11.90

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
BRIEF-Equinor Acquires A 9.8% Minority Stake In Ørsted
BRIEF-Equinor Acquires A 9.8% Minority Stake In Ørsted
Oct 7, 2024
Oct 7 (Reuters) - Equinor ASA ( EQNR ): * EQUINOR ACQUIRES A 9.8% MINORITY STAKE IN ØRSTED * INTENDS TO INCREASE ØRSTED STAKE TO 10% PENDING APPROVALS * ØRSTED HOLDING VALUED AT AROUND $2.5 BILLION * BECOMES SECOND LARGEST SHAREHOLDER IN ØRSTED * TRANSACTION WILL BE EXECUTED WITHIN EQUINOR'S COMMUNICATED FINANCIAL FRAMEWORK. * SUBJECT TO OBTAINING REGULATORY APPROVALS UNDER...
Pfizer wins bid to invalidate GSK's patents over RSV vaccine
Pfizer wins bid to invalidate GSK's patents over RSV vaccine
Oct 7, 2024
LONDON, Oct 7 (Reuters) - Pfizer ( PFE ) on Monday won a bid in a London court to invalidate two of GSK's patents relating to a respiratory syncytial virus (RSV) vaccine. The two pharmaceutical giants are among a number of companies in competition for a vaccine for RSV, which typically causes cold-like symptoms but is also a leading cause...
CAMP4 Therapeutics seeks up to $80 mln proceeds in US IPO
CAMP4 Therapeutics seeks up to $80 mln proceeds in US IPO
Oct 7, 2024
Oct 7 (Reuters) - CAMP4 Therapeutics, a biopharmaceutical company backed by healthcare giant Kaiser Permanente, said on Monday it is targeting proceeds of up to $80 million for its initial public offering in the United States. ...
Hedge fund Elliott loses appeal against dismissal of LME nickel lawsuit
Hedge fund Elliott loses appeal against dismissal of LME nickel lawsuit
Oct 7, 2024
LONDON, Oct 7 (Reuters) - Hedge fund Elliott Associates on Monday lost an appeal against the dismissal of its lawsuit against the London Metal Exchange over billions of dollars of cancelled nickel trades. The LME suspended trading and annulled $12 billion in nickel trades in March 2022 when prices shot to records above $100,000 a metric ton in a few...
Copyright 2023-2026 - www.financetom.com All Rights Reserved